TIDMPOLX

RNS Number : 5919O

Polarean Imaging PLC

03 October 2019

Polarean Imaging Plc

("Polarean" or the "Company")

Polarean notes statement from Amphion Innovations

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, notes the announcement made by its partner company, Amphion Innovations Plc ("Amphion") that 750,000 shares in Polarean have been sold for partial repayment of Amphion's loan facility which was originally announced on 5 June 2014 and most recently amended as announced on 25 September 2019.

Following this sale, Amphion holds 15,972,523 ordinary shares of Polarean, representing 13.96% of the Company's issued share capital.

The full TR-1 disclosure is set out below.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

TR-1: Standard form for notification of major holdings

 
 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
  to the FCA in Microsoft Word format if possible)(i) 
 
 1a. Identity of the issuer or the                                        Polarean Imaging plc 
  underlying issuer of existing shares 
  to which voting rights are attached(ii) 
  : 
                                                              ------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 Non-UK issuer 
                                                                                                    ----- 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights                                                          X 
                                                                                                    ----- 
 An acquisition or disposal of financial instruments 
                                                                                                    ----- 
 An event changing the breakdown of voting rights 
                                                                                                    ----- 
 Other (please specify)(iii) : 
                                                                                                    ----- 
 3. Details of person subject to the notification obligation(iv) 
 Name                                                          Amphion Innovations plc 
 City and country of registered office 
  (if applicable) 
 4. Full name of shareholder(s) (if different from 3.)(v) 
 Name 
                                                              ------------------------------------------- 
 City and country of registered office 
  (if applicable) 
                                                              ------------------------------------------- 
 5. Date on which the threshold was                            2 October 2019 
  crossed or reached(vi) : 
                                                              ------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):                2 October 2019 
                                                              ------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                              % of voting       % of voting rights    Total of both      Total number 
                            rights attached      through financial     in % (8.A +      of voting rights 
                            to shares (total        instruments            8.B)          of issuer(vii) 
                                of 8. A)           (total of 8.B 
                                                    1 + 8.B 2) 
                          ------------------  ---------------------  --------------  -------------------- 
 Resulting situation 
  on the date 
  on which threshold 
  was crossed 
  or reached               13.96%                                                     114,438,600 
                          ------------------  ---------------------  --------------  -------------------- 
 Position of 
  previous notification 
  (if 
  applicable)              14.96% 
                          ------------------  ---------------------  --------------  -------------------- 
 
 
 
 8. Notified details of the resulting situation on the date on which the 
  threshold was crossed or reached(viii) 
 A: Voting rights attached to shares 
 Class/type of       Number of voting rights(ix)                              % of voting rights 
  shares 
  ISIN code (if 
  possible) 
                    ------------------------------------------------------- 
                             Direct                      Indirect                      Direct                  Indirect 
                       (Art 9 of Directive         (Art 10 of Directive          (Art 9 of Directive     (Art 10 of Directive 
                           2004/109/EC)                2004/109/EC)             2004/109/EC) (DTR5.1)        2004/109/EC) 
                             (DTR5.1)                   (DTR5.2.1)                                            (DTR5.2.1) 
                    ------------------------  -----------------------------  -------------------------  --------------------- 
 GB008BVVT4H71       15,972,523                                               13.96% 
                    ------------------------  -----------------------------  -------------------------  --------------------- 
 
 
 SUBTOTAL 8. 
  A                                        15,972,523                                             13.96% 
                    -------------------------------------------------------  ------------------------------------------------ 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
  (DTR5.3.1.1 (a)) 
 Type of financial   Expiration   Exercise/                            Number of voting                  % of voting rights 
  instrument          date(x)      Conversion Period(xi)                rights that may 
                                                                        be acquired if 
                                                                        the instrument 
                                                                        is 
                                                                        exercised/converted. 
                    -----------  -----------------------------------  --------------------------------  --------------------- 
 
 
 
                                  SUBTOTAL 8. B 1 
                                 -----------------------------------  --------------------------------  --------------------- 
 
 B 2: Financial Instruments with similar economic effect according to Art. 
  13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of        Expiration        Exercise/               Physical or              Number of             % of voting rights 
  financial      date(x)           Conversion              cash                     voting rights 
  instrument                       Period (xi)             settlement(xii) 
               ----------------  ----------------------  -----------------------  -------------------- 
 
 
 
                                                          SUBTOTAL 8.B.2 
                                                         -----------------------  -------------------- 
 
 
 
 
 9. Information in relation to the person subject to the notification obligation 
  (please mark the applicable box with an "X") 
 Person subject to the notification obligation is not controlled                          X 
  by any natural person or legal entity and does not control any other 
  undertaking(s) holding directly or indirectly an interest in the 
  (underlying) issuer(xiii) 
 Full chain of controlled undertakings through which the voting rights 
  and/or the financial instruments are effectively held starting with 
  the ultimate controlling natural person or legal entity(xiv) (please 
  add additional rows as necessary) 
     Name(xv)         % of voting rights      % of voting rights        Total of both if 
                        if it equals or        through financial      it equals or is higher 
                      is higher than the       instruments if it       than the notifiable 
                     notifiable threshold     equals or is higher           threshold 
                                              than the notifiable 
                                                   threshold 
                   -----------------------  ---------------------  -------------------------- 
 
 
 
 
 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder 
                                            ------------------------------------------------- 
 The number and % of voting rights 
  held 
                                            ------------------------------------------------- 
 The date until which the voting rights 
  will be held 
                                            ------------------------------------------------- 
 
 11. Additional information(xvi) 
 
 
 
 
 Place of completion   London, UK 
 Date of completion    2 October 2019 
                      --------------- 
 

Enquiries:

 
Polarean Imaging plc                              www.polarean.com / www.polarean-ir.com 
Richard Hullihen, Chief Executive Officer                                Via Walbrook PR 
Richard Morgan, Chairman 
 
SP Angel Corporate Finance LLP                                       Tel: +44 (0)20 3470 
                                                                                    0470 
David Hignell / Soltan Tagiev (Corporate Finance) 
Vadim Alexandre / Rob Rees (Corporate Broking) 
 
Walbrook PR                          Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com 
Anna Dunphy / Paul McManus                        Mob: +44 (0)7879 741 001 / +44 (0)7980 
                                                                                 541 893 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLMTBTTMBMMTRL

(END) Dow Jones Newswires

October 03, 2019 02:00 ET (06:00 GMT)

Polarean Imaging (LSE:POLX)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Polarean Imaging.
Polarean Imaging (LSE:POLX)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Polarean Imaging.